(Q35890474)

10 August 2017

1 reference

title

Endocrine modifications and interventions during critical illness (English)

1 reference

10 August 2017

2

Greet Van den Berghe

0 references

author name string

Frank Weekers

series ordinal

1

1 reference

10 August 2017

language of work or name

1 reference

1 August 2004

1 reference

Proceedings of the Nutrition Society

10 August 2017

published in

1 reference

10 August 2017

volume

63

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

443-450

1 reference

Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Anterior pituitary function during critical illness and dopamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Testosterone administration in severe burns ameliorates muscle catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Insulinlike growth factor 1 production is inhibited in human sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Increased mortality associated with growth hormone treatment in critically ill adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Effect of growth hormone on muscle and liver protein synthesis in septic rats receiving glutamine-enriched parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Effects of growth hormone administration on fuel oxidation and thyroid function in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Growth hormone and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

The controversy of the treatment of critically ill patients with thyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

The role of insulin, growth hormone and IGF-I as anabolic agents in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Effect of surgical stress on pituitary-testicular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Reversal of catabolism by beta-blockade after severe burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Effect of Tri-Iodothyronine Replacement on the Metabolic and Pituitary Responses to Starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Physiological and pathophysiological aspects of thyrotropin-releasing hormone gene expression in the human hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

A Paradoxical Gender Dissociation within the Growth Hormone/Insulin-Like Growth Factor I Axis during Protracted Critical Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2004373

21 January 2018

Identifiers

DOI

10.1079/PNS2004373

1 reference

10 August 2017

1 reference